Germany’s healthcare system is undertaking one of the most significant healthcare reforms in its history. The 2025 hospital reform, anchored by the Krankenhausversorgungsverbesserungsgesetz (KHVVG), brings fundamental changes to care delivery, funding structures, and institutional roles. For medtech companies, these changes present both challenges and opportunities that demand careful navigation and strategic foresight.
Watch our webinar recording to explore the impact of Germany’s 2025 hospital reform and what it means for medtech companies operating in or entering the market.
This session covers:
- Core components of the Krankenhausversorgungsverbesserungsgesetz (KHVVG), including service group classifications, Level 1i hospital types, and hybrid DRG funding models.
- Implications of increased hospital specialization and stricter quality criteria for product demand, procurement, and provider partnerships.
- The evolving role of outpatient care, and how the rise of cross-sector Level 1i facilities will reshape procedure allocation and point-of-care needs.
- New pricing and market access strategies in response to facility budget shifts, case volume changes, and financial predictability mechanisms.
- How medtech companies can transform commercial strategies, value communication, and sales force models to stay competitive in a rapidly changing system.
